Inventor
TESTER RICHLAND WAYNE
US19 patents
⚠️ This page may combine multiple inventors who share the name “TESTER RICHLAND WAYNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE AVILOMICS RES INC
8 patentsUS8609679B2Dec 17, 2013
2,4-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC84 citations99
US9212181B2Dec 15, 2015
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC34 citations98
US8710222B2Apr 29, 2014
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC52 citations97
US9409921B2Aug 9, 2016
2,4-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC25 citations94
US9296737B2Mar 29, 2016
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC27 citations94
US9604936B2Mar 28, 2017
Besylate salt of a BTK inhibitor
CELGENE AVILOMICS RES INC13 citations83
US9540335B2Jan 10, 2017
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC5 citations83
US9108927B2Aug 18, 2015
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC9 citations83
CELGENE CAR LLC
8 patentsUS9987276B2Jun 5, 2018
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE CAR LLC23 citations94
US10010548B2Jul 3, 2018
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC15 citations92
US10596172B2Mar 24, 2020
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC5 citations84
US11351168B1Jun 7, 2022
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC2 citations73
US10828300B2Nov 10, 2020
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE CAR LLC3 citations73
US10570099B2Feb 25, 2020
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE CAR LLC2 citations72
US10005738B2Jun 26, 2018
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE CAR LLC3 citations72
US11292772B2Apr 5, 2022
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE CAR LLC0 citations62